About Us  |  BVA-100  |  Investor Relations  |  IDANT Division  |  Contact Us
 

Welcome to DAXOR Corporation!

 
 

2/15/2012 - Daxor Announces Receipt of Order Granting Request to Withdraw Petition for Review and Notice of Finality

  

2/10/2012 - Society of Critical Care Medicine Conference in Houston Has 3 Research Studies Presented Involving the Daxor BVA-100 Blood Volume Analyzer

  

2/1/2012 - Daxor Announces that Shertech Pharmacy Corp. Acquires BVA-100 Blood Volume Analyzer to Service Multiple Hospitals

  
 

______________________

 
     
  September 2011 Form 10-Q  
  2011 Proxy Statement  
  2010 Annual Report  
  2010 Year End Earnings  
  DAXOR Corporation Newsletter; Issue 1, March 2010  
  2010 Form 10-K  
 

DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility.


The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.

 

Find out more about the BVA-100 >

 

See where blood volume tests are being performed >

 

Watch San Antonio's KENS5 station feature on the BVA-100
(MPEG video; 19 MB) >


 

Corporate
Headquarters

350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806


© 2012 DAXOR Corporation. All Rights Reserved.